The estimated Net Worth of Jade Brown is at least 693 千$ dollars as of 22 June 2006. Jade Brown owns over 9,500 units of CTI BioPharma Corp stock worth over 618,084$ and over the last 19 years Jade sold CTIC stock worth over 75,154$.
Jade has made over 4 trades of the CTI BioPharma Corp stock since 2005, according to the Form 4 filled with the SEC. Most recently Jade sold 9,500 units of CTIC stock worth 13,395$ on 22 June 2006.
The largest trade Jade's ever made was selling 18,667 units of CTI BioPharma Corp stock on 28 December 2005 worth over 40,694$. On average, Jade trades about 7,028 units every 29 days since 2005. As of 22 June 2006 Jade still owns at least 67,996 units of CTI BioPharma Corp stock.
You can see the complete history of Jade Brown stock trades at the bottom of the page.
Jade's mailing address filed with the SEC is 501 ELLIOTT AVE. W., SUITE 400, SEATTLE, WA, 98119.
Over the last 21 years, insiders at CTI BioPharma Corp have traded over 80,110,449$ worth of CTI BioPharma Corp stock and bought 9,566,060 units worth 25,487,533$ . The most active insiders traders include Partners L P/Ilbiotechnolog...、Partners L P/Ilbiotechnolog...、Advisors Llc Orbi Med Capit.... On average, CTI BioPharma Corp executives and independent directors trade stock every 26 days with the average trade being worth of 1,223,687$. The most recent stock trade was executed by Adam R Craig on 24 January 2023, trading 85,317 units of CTIC stock currently worth 71,666$.
cti was founded on the belief that a coalition between unique scientific technology and its strong desire to “do right” by the patient could help us achieve our mission to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. we strive to do business better than other biopharmaceutical companies. better means a more collaborative, well-trained team environment willing to institute novel approaches to scientific discovery and business opportunities. a willingness to push the limits to achieve challenging goals is the essential attribute that sets cti employees apart.
CTI BioPharma Corp executives and other stock owners filed with the SEC include: